Qiagen NV (QIA):企業の財務・戦略的SWOT分析

◆英語タイトル:Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME2456FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Qiagen NV (QIA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and also through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen NV Key Recent Developments

Mar 02,2021: QIAGEN launches QIAcube Connect MDx platform for automated sample processing in diagnostic labs
Feb 22,2021: QIAGEN Expands Supervisory Board With Appointment of a New Member
Feb 18,2021: QIAGEN announces digital partner program with five initial partnerships
Jan 28,2021: QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing
Jan 19,2021: QIAGEN adopts GNS Healthcare’s Gemini – The in silico Patient across multiple cancers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Qiagen NV – Key Facts
Qiagen NV – Key Employees
Qiagen NV – Key Employee Biographies
Qiagen NV – Major Products and Services
Qiagen NV – History
Qiagen NV – Company Statement
Qiagen NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Qiagen NV – Business Description
Product Category: Consumables and Related Revenues
Overview
Performance
Product Category: Instrumentation
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific, Japan and Rest of World
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
R&D Overview
Qiagen NV – Corporate Strategy
Qiagen NV – SWOT Analysis
SWOT Analysis – Overview
Qiagen NV – Strengths
Qiagen NV – Weaknesses
Qiagen NV – Opportunities
Qiagen NV – Threats
Qiagen NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Qiagen NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Qiagen NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Qiagen NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2021: QIAGEN launches QIAcube Connect MDx platform for automated sample processing in diagnostic labs
Feb 22, 2021: QIAGEN Expands Supervisory Board With Appointment of a New Member
Feb 18, 2021: QIAGEN announces digital partner program with five initial partnerships
Jan 28, 2021: QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing
Jan 19, 2021: QIAGEN adopts GNS Healthcare’s Gemini – The in silico Patient across multiple cancers
Jan 08, 2021: QIAGEN announces appointment of new supervisory Board Member
Dec 08, 2020: Qiagen increases outlook for 2020 and 2021
Nov 23, 2020: Qiagen opens new facilities in Barcelona Science Park to increase action capacity against COVID-19
Nov 19, 2020: Qiagen and BioNTech to develop test for head and neck cancer
Nov 17, 2020: Leading Diagnostics Companies join forces to establish the access to comprehensive genomic profiling coalition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Qiagen NV, Key Facts
Qiagen NV, Key Employees
Qiagen NV, Key Employee Biographies
Qiagen NV, Major Products and Services
Qiagen NV, History
Qiagen NV, Subsidiaries
Qiagen NV, Joint Venture
Qiagen NV, Key Competitors
Qiagen NV, Ratios based on current share price
Qiagen NV, Annual Ratios
Qiagen NV, Annual Ratios (Cont...1)
Qiagen NV, Annual Ratios (Cont...2)
Qiagen NV, Interim Ratios
Qiagen NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Qiagen NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Qiagen NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Qiagen NV (QIA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bawag Psk
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EDF Luminus SA:企業の発電所・SWOT分析2018
    EDF Luminus SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務分析
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pakistan Water and Power Development Authority-エネルギー分野:企業M&A・提携分析
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Carlisle Companies Incorporated:戦略・SWOT・企業財務分析
    Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • San Diego Gas & Electric Co:電力:M&Aディール及び事業提携情報
    Summary San Diego Gas & Electric Company (SDGE), a subsidiary of Sempra Energy is an energy service provider that offers electric generation, transmission and distribution services. The company also distributes natural gas. Its residential services include payment and bill assistance, start, stop, m …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …
  • Emory University-製薬・医療分野:企業M&A・提携分析
    Summary Emory University (Emory) is an educational service provider that offers academic degrees and programs through its arts colleges and graduate and professional schools. The university offers degree programs in the areas of business, law, medicine, nursing, public health, theology, and online c …
  • Elmet Technologies, Inc.:企業の戦略・SWOT・財務情報
    Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chiesi USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi USA Inc (Chiesi USA), a subsidiary of Chiesi Farmaceutici S.p.A, is a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. The company's product portfol …
  • Bloomberg L.P.:企業の戦略・SWOT・財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Valeo SA (FR):企業の財務・戦略的SWOT分析
    Valeo SA (FR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆